Information on selecting the most advantageous offer - request for proposal RFP 022775 – ONCO-32 – DEVELOPMENT AND MANUFACTURE OF A SINGLE API IN GMP CONDITIONS

In connection with obtaining from the National Centre for Research and Development a grant for the project „Clinical development of an innovative anti-cancer drug using the mechanism of  reactivation of p53 protein” (project no. MAZOWSZE/0012/19) under R&D programme ,,Ścieżka dla Mazowsza”, acting on the basis of Article 10 of the financial project support contract Adamed Pharma S.A. informs that the conducted procedure has not been resolved - no offers.